Clincosm LogoSign in Get a demo

Brain Metastases

Showing 26 - 50 of 269
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Metastases, Nonsmall Cell Lung Cancer Stage III Trial in Winston-Salem (MRI of the Brain, Blood draws, Quality of Life

Not yet recruiting
  • Brain Metastases
  • Nonsmall Cell Lung Cancer Stage III
  • MRI of the Brain
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Cente
Jan 19, 2023

Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Shanghai (Pyrotinib Plus Capecitabine combined with brain

Active, not recruiting
  • Breast Cancer
  • +2 more
  • Pyrotinib Plus Capecitabine combined with brain radiotherapy
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 14, 2023

Brain Metastases, HER2-positive Breast Cancer Trial (Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine)

Not yet recruiting
  • Brain Metastases
  • HER2-positive Breast Cancer
  • Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine
  • (no location specified)
Jan 10, 2023

Metastatic Solid Tumor, Brain Metastases Trial in Houston (Trastuzumab emtansine, Tucatinib)

Not yet recruiting
  • Metastatic Solid Tumor
  • Brain Metastases
  • Houston, Texas
    M D Anderson Cancer Center
Dec 30, 2022

Brain Metastases, Leptomeningeal Metastasis Trial in United States (GDC-0084, whole brain radiation therapy radiation)

Recruiting
  • Brain Metastases
  • Leptomeningeal Metastasis
  • GDC-0084
  • whole brain radiation therapy radiation
  • Miami, Florida
  • +9 more
Jan 3, 2023

Brain Metastases, Brain Cancer Trial in Miami (18F-Fluciclovine)

Not yet recruiting
  • Brain Metastases
  • Brain Cancer
  • Miami, Florida
    Miami Cancer Institute at Baptist Health South Florida
Jan 3, 2023

Brain Metastases Trial in New York (18F-FCH PET Scan)

Completed
  • Brain Metastases
  • 18F-FCH PET Scan
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 15, 2022

Treatments for Brain Metastases With Poor Prognostic Factors

Enrolling by invitation
  • Brain Metastases
  • neurosurgical resection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 13, 2022

Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in

Recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Brain Metastases
  • Radiotherapy combined with PD-1 inhibitors
  • Changsha, Hunan, China
    Xiangya Hospital, Central South University
Nov 27, 2022

NSCLC, EGFR Gene Mutation, Brain Metastases Trial in Worldwide (AZD3759, Erlotinib, Gefitinib)

Completed
  • Non-small Cell Lung Cancer
  • +2 more
  • Hefei, Anhui, China
  • +57 more
Nov 18, 2022

Metastatic Breast Cancer, Brain Metastases Trial in Tampa (Nivolumab, Stereotactic Radiosurgery)

Active, not recruiting
  • Metastatic Breast Cancer
  • Brain Metastases
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 17, 2022

Non-squamous Non-small-cell Lung Cancer, Brain Metastases Trial in Guangzhou (Camrelizumab, Pemetrexed, Carboplatin)

Active, not recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • Brain Metastases
  • Guangzhou, Guangzhou, China
    Li-Kun Chen
Nov 13, 2022

Target Therapy for Brain Metastases With EGFR Mutation

Not yet recruiting
  • Brain Metastases
  • Surgery or Radiotherapy
  • before or after target therapy
  • (no location specified)
Nov 8, 2022

Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,

Recruiting
  • Brain Metastases
  • +3 more
  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
  • Bevacizumab Injection
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 12, 2022

Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer Trial (Trastuzumab,

Recruiting
  • Brain Metastases
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Nov 8, 2022

Lung Cancer, Lung Cancer Metastatic, Brain Metastases Trial in United States (Stereotactic Radiosurgery, Cerebrospinal fluid

Recruiting
  • Lung Cancer
  • +5 more
  • Stereotactic Radiosurgery
  • Cerebrospinal fluid collection
  • Basking Ridge, New Jersey
  • +6 more
Nov 11, 2022

Advanced Cancer, Brain Metastases Trial in New Orleans (DM-CHOC-PEN)

Completed
  • Advanced Cancer
  • Brain Metastases
  • New Orleans, Louisiana
    Tulane University Medical Center
Nov 3, 2022

Melanoma, Brain Metastases Trial in Spain (Ipilimumab)

Completed
Has Results
  • Melanoma
  • Brain Metastases
  • Badalona, Spain
  • +11 more
Oct 10, 2022

Brain Metastases, HR+ Metastatic Breast Cancer Trial in Tampa (Stereotactic Radiosurgery (SRS), Abemaciclib, Endocrine therapy)

Recruiting
  • Brain Metastases
  • HR+ Metastatic Breast Cancer
  • Stereotactic Radiosurgery (SRS)
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Nov 1, 2022

Non Small Cell Lung Cancer, Stage IV NSCLC, Brain Metastases Trial in Hangzhou (Hypofractionated Stereotactic Radiotherap)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Hypofractionated Stereotactic Radiotherap
  • Hangzhou, China
    Kaicheng Pan
Oct 18, 2022

Malignant Melanoma, BRAF V600 Mutation, Brain Metastases Trial in France (Stereotaxic radiosurgery (SRS), Binimetinib Oral

Recruiting
  • Malignant Melanoma
  • +2 more
  • Stereotaxic radiosurgery (SRS)
  • +3 more
  • Bobigny, France
  • +20 more
Oct 7, 2022

Small-cell Lung Cancer, Brain Metastases Trial in United States (Carboplatin, Etoposide, Atezolizumab)

Active, not recruiting
  • Small-cell Lung Cancer
  • Brain Metastases
  • Duarte, California
  • +5 more
Oct 10, 2022

Radiation-Induced Neurocognitive Decline Following SRS of Newly

Suspended
  • Brain Metastases
  • +3 more
    • Chapel Hill, North Carolina
      University of North Carolina at Chapel Hill, Department of Radia
    Oct 7, 2022

    Brain Metastases Trial in Seoul (BT-M01)

    Recruiting
    • Brain Metastases
    • BT-M01
    • Seoul, Song-pa Gu, Korea, Republic of
      Asan Medical Center
    Oct 6, 2022

    Brain Metastases Trial in Toronto (Sunitinib)

    Completed
    • Brain Metastases
    • Toronto, Ontario, Canada
      University Health Network, Princess Margaret Hospital
    Oct 6, 2022